Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Baricitinib was effective in treating both early and late onset alopecia areata.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

An 8-year-old girl has a rare, irreversible hair loss condition caused by a genetic mutation.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

LONRF1 is important for oxidative damage response and tissue remodeling during wound healing.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

A faulty KLHL24 gene leads to hair loss by damaging hair follicle stem cells.

ROR2 is crucial for hair follicle stem cell maintenance and self-renewal.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Two new proteins, hKAP1.6 and hKAP1.7, are found in the hair follicle cortex.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

Inflammatory diets may increase the risk and severity of alopecia areata.

Changing CDK4 levels affects the number of stem cells in mouse hair follicles.

ARWH is a rare hair disorder with no cure, but potential treatments include minoxidil and other therapies.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Polyunsaturated fatty acids, like arachidonic acid and eicosapentaenoic acid, can promote hair growth and may help treat hair loss.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Ruxolitinib can help regrow hair in severe alopecia areata.

AGD1's PH domain is essential for its role in root hair growth and polarity.

Tofacitinib may help treat hair loss in children with alopecia areata.